Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of Enzyme Inhibition and Medicinal Chemistry|March 13, 2010
Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part IIVanessa Desplat, Stephane Moreau, Aurore Gay, et al.Plos One|March 13, 2009
Molecular blocking of CD23 supports its role in the pathogenesis of arthritisJérôme Rambert, Maria Mamani-Matsuda, Daniel Moynet, et al.Infection and Immunity|October 7, 2009
CD23 mediates antimycobacterial activity of human macrophagesM Djavad Mossalayi, Ioannis Vouldoukis, Maria Mamani-Matsuda, et al.European Journal of Medicinal Chemistry|March 6, 2016
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell linesVanessa Desplat, Marian Vincenzi, Romain Lucas, et al.Bioorganic & Medicinal Chemistry|October 20, 2006
Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agentsJean Guillon, Isabelle Forfar, Maria Mamani-Matsuda, et al.European Journal of Medicinal Chemistry|May 29, 2013
Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2Jean Guillon, Marc Le Borgne, Charlotte Rimbault, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 22, 2011
Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivativesVanessa Desplat, Stéphane Moreau, Solene Belisle-Fabre, et al.Chemmedchem|February 21, 2017
Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia CellsVanessa Desplat, Marian Vincenzi, Romain Lucas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2021
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in <i>FLT3</i>-ITD Acute Myeloid LeukemiaPierre-Yves Dumas, Arnaud Villacreces, Amélie V Guitart, et al.Cancers|January 21, 2022
Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic CellsMarine Dupont, Mathilde Huart, Claire Lauvinerie, et al.Pageof 4